Case-Based Roundtable

General Dermatology 

Eczema

Chronic Hand Eczema

Chronic Spontaneous Urticaria 

Alopecia

Aesthetics

Vitiligo

COVID-19

Actinic Keratosis 

Precision Medicine and Biologics

Rare Disease

Wound Care

Rosacea 

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

Melasma

NP and PA

Skin Cancer (Nonmelanoma)

Skin Cancer

Hidradenitis Suppurativa

Drug Watch

Pigmentary Disorders 

Acne 

Pediatric Dermatology

Practice Management 

Prurigo Nodularis

Buy-and-Bill

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Perspectives in Dermatology

Polls

Spot Test

Editorial Advisory Board

Partners

Subscribe

Maddi Hebebrand is an associate editor of 

and joined the MJH Life Sciences team in May 2024. She attended Baldwin Wallace University, studying Media Production and Film, and received her Masters in Digital Media from Ohio University. When she's not writing, Maddi loves to read, attend concerts and spend time with her family. 

Articles

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Daily Derm Times: May 9, 2025

Jennifer Fisher, MMSc, PA-C, is a board-certified dermatology physician assistant and medical writer in Connecticut.

Abrocitinib’s targeted inhibition of JAK1 offers effective control of AD, but may, in rare instances, lead to a shift in immune expression resulting in paradoxical psoriasis.

New-Onset Psoriasis After Abrocitinib Treatment for Atopic Dermatitis 

Johnson & Johnson's icotrokinra shows promising results in treating moderate plaque psoriasis, especially in challenging areas like the scalp and genitals.

Icotrokinra Effective in High-Impact Psoriasis Areas

and joined the MJH Life Sciences team in February 2023. She attended Kent State University and earned a Bachelor of Science degree in journalism with minors in public relations and creative writing. She enjoys making and listening to music, reading, and spending time with her cats, Astrid and Marceline.

Explore the evolving landscape of dermatology as experts emphasize the importance of cross-specialty collaboration and patient-centered care in aesthetic medicine.

Collaborating for Better Aesthetics: Why Dermatology Matters in Multispecialty Medicine

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

Chapter 1

OX40-Ligand (OX40L) Pathway Resource Center

Highlighting unmet needs in atopic dermatitis (AD) and understanding disease pathogenesis

Expert Insights - What are Antigen-presenting Cells and Their Role in T-cell Activation?

This material is for scientific and medical education purposes only, and is intended only for US healthcare professionals.

MAT-US-2410187 v1.0 - P Expiration Date: 11/08/2025